NKGen Biotech Inc [NASDAQ: NKGN] plunged by -$0.33 during the normal trading session on while it closed the day at $0.19.
NKGen Biotech Inc stock has also loss -65.84% of its value over the past 7 days. However, NKGN stock has declined by -48.60% in the 3 months of the year. Over the past six months meanwhile, it has lost -74.94% and lost -70.80% year-on date.
The market cap for NKGN stock reached $8.60 million, with 44.95 million shares outstanding and 27.98 million shares in the current float. Compared to the average trading volume of 3.91M shares, NKGN reached a trading volume of 8034985 in the most recent trading day, which is why market watchdogs consider the stock to be active.
NKGN stock trade performance evaluation
NKGen Biotech Inc [NKGN] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -65.84. With this latest performance, NKGN shares dropped by -60.84% in over the last four-week period, additionally sinking by -74.94% over the last 6 months – not to mention a drop of -76.00% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for NKGN stock in for the last two-week period is set at 32.36, with the RSI for the last a single of trading hit 25.60, and the three-weeks RSI is set at 36.50 for NKGen Biotech Inc [NKGN]. The present Moving Average for the last 50 days of trading for this stock 0.5455, while it was recorded at 0.4612 for the last single week of trading, and 0.7376 for the last 200 days.
NKGen Biotech Inc [NKGN]: An insightful look at the core fundamentals
NKGen Biotech Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.02 and a Current Ratio set at 0.02.
